Compare Align Technology, Inc. (ALGN) vs Paychex, Inc. (PAYX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Paychex, Inc. — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Paychex, Inc. trades at $108.43 (market cap $38.25B). The key difference: Paychex, Inc. is far larger — about 3× Align Technology, Inc.'s market cap, and Paychex, Inc. pays a 4.43% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PAYX | |
|---|---|---|
Market Cap | $12.86B | $38.25B |
Sector | Health | Industrials |
52-Week High | $207.19 | $147.99 |
52-Week Low | $124.88 | $85.57 |
Enterprise Value | $11.92B | $41.73B |
Dividend Yield | — | 4.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Paychex (PAYX) trades at $107.54, up 1.16% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 27.03% net margin and 44.77% ROE, though valuation ratios like P/E of 22 and P/S of 5.95 are elevated. Recent Q1 2026 EPS of $1.32 beat expectations, and the company maintains dividend payments with a $1.19 distribution scheduled for May 29, 2026. Cash flow from operations remains robust at $1.90B for 2025.
Outlook is cautiously optimistic with a consensus price target of $110.00, though analyst ratings are mixed (63.33% Hold). Key risks include macroeconomic sensitivity to small business hiring and integration challenges from acquisitions. The stock's current price near resistance at $110 suggests limited near-term upside without significant catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
